跳至主要内容
临床试验/IRCT20170513033941N59
IRCT20170513033941N59已完成3 期

Effects of melatonin supplementation on clinical status and metabolic profiles in overweight or obese women with fibrocystic breast disease

Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Patients aged 18-45 years
  • women diagnosed with fibrocystic breast disease
  • having moderate or severe cyclic mastalgia

排除标准

  • Malignant breast diseases
  • Taking medicines for reducing pain (such as danazol, tamoxifen, bromocriptine) over the past three months
  • Menopause women
  • Pregnant or breastfeeding women
  • Psychological diseases
  • The consumption of any herbal or chemical sedative or hormonal medicines during the study
  • Unwillingness to cooperate

研究者

相似试验

Effects of melatonin supplementation in the... | 临床试验